Eli Lilly stops trial of antibody drug over safety concern

preview_player
Показать описание
U.S. drugmaker Eli Lilly said that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by President Donald Trump has been paused because of a safety concern.


Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Рекомендации по теме